Levetiracetam Tillomed

Levetiracetam, the active ingredient in Levetiracetam Tillomed, is an antiepileptic presented as an intravenous solution for intravenous use. It treats partial‑onset seizures and generalized tonic‑clonic seizures as adjunct therapy in patients with epilepsy.

GNH USA supplies Levetiracetam Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levetiracetam is an antiepileptic medication used to manage seizure disorders.

- Partial‑onset seizures: reduces seizure frequency when added to existing therapy. - Generalized tonic‑clonic seizures: provides adjunctive control of seizure activity. - Adjunct therapy for epilepsy: enhances overall seizure management in patients with refractory epilepsy.

Levetiracetam may cause a range of adverse reactions.

Common Side Effects: - Dizziness: mild to moderate sensation of light‑headedness. - Fatigue: generalized tiredness or lack of energy. - Somnolence: increased sleepiness during the day. - Headache: mild to moderate cranial pain. - Irritability: mood changes or increased agitation. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: rare skin blistering disorder. - Blood dyscrasias: neutropenia or thrombocytopenia. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Severe depression: marked mood disturbances requiring intervention. - Respiratory depression: rare but potentially life‑threatening breathing difficulty.

When using Levetiracetam, consider the following safety measures.

- Renal impairment: adjust dosing according to renal function. - Pregnancy: use only if the potential benefit justifies the risk. - Hepatic impairment: monitor liver function tests regularly. - Psychiatric symptoms: observe for mood changes, depression, or suicidal thoughts. - Concomitant CNS depressants: use with caution due to additive sedation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levetiracetam can interact with other medicines; awareness of the level of interaction is important.

Major Interactions (Avoid): - Enzyme‑inducing antiepileptics (e.g., carbamazepine, phenytoin): may lower levetiracetam plasma concentrations. - Strong CYP inducers (e.g., rifampin): can reduce therapeutic effect.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, opioids): may increase sedation and respiratory depression. - Alcohol: can enhance dizziness and drowsiness. - Immunosuppressants (e.g., azathioprine): monitor blood counts for potential additive marrow suppression.